800 jobs created in Molsheim thanks to Merck’s investment

Merck persists and signs in France. The German laboratory will invest 130 million euros in its plant in Molsheim (Bas-Rhin) and create 800 jobs there by 2028. Several new buildings will be built, including a single-use equipment production unit, delivered in 2024.”With this investment, we are renewing our confidence in France for its employment pool and its talents, says Matthias Henzel, Managing Director of the branch of Merck dedicated to life sciences (lipids, genetic modification tools, etc.), which represents approximately half of its total activity. By increasing production at Molsheim, our third largest site in the world, we are also contributing to European health sovereignty..”

This investment is the last phase of the Mobius project, announced at the start of 2021. It had already led the laboratory to inject 175 million euros in France (where it has 11 sites), including 25 million in Molsheim. What to build…